cluding the type of rhinitis present , and patient age (refer to Tables 3, 4, and 5).1
itis (PAR)
NS for associated ocular symptoms ices are typically better for mixed rhinitis
ate for PRN use in episodic AR because of relatively rapid onset of action ms R
ce impairment, anticholinergic effects of first-generation antihistamines, second-generation tadine without sedation at recommended doses
priate for very severe nasal symptoms r corticosteroids, which should be discouraged
patients who have both conditions
nsion ntihistamines (with loratadine as usual comparator)
appropriate for PRN use in episodic AR n antihistamines with clinically significant effect on nasal congestion
or vasomotor rhinitis
on ur ongestion
stamines, usually occurs within 12 hours, and may start as early as 3 to hours in some patients RA for SAR and PAR r symptoms of AR lso effective for some nonallergic rhinitis
nstrated when used at recommended doses cur, and nasal septal perforation rarely reported
7 days, full benefit may take weeks ure protects for 4 to 8 hours against allergic response mparison to leukotriene antagonists and antihistamines
estion, but inappropriate for daily use because of the risk for rhinitis medicamentosa nt nasal mucosal edema present
